Amirali B. Bukhari

2.3k citations

15 papers · 1.7k indexed · 1 hit paper · h-index 12

Co-authors: Abhijit De Renu Malhotra Frency Varghese Rohit Srivastava Aravind Kumar Rengan Arpan Pradhan Rinti Banerjee Armin M. Gamper
Topics: DNA Repair Mechanisms (3 papers)Cancer-related Molecular Pathways (3 papers)Cellular Mechanics and Interactions (2 papers)
Cited by: Biomaterials Oncology Cancer Research
Journals: Journal of Clinical Investigation Nano Letters PLoS ONE
Partner nations: India Canada China

In The Last Decade

Amirali B. Bukhari

15 papers receiving 1.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples

2014 992 citations Frency Varghese, Amirali B. Bukhari et al. PLoS ONE profile →

Peers

Countries citing papers authored by Amirali B. Bukhari

Since Specialization

Citations

This map shows the geographic impact of Amirali B. Bukhari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amirali B. Bukhari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amirali B. Bukhari more than expected).

Fields of papers citing papers by Amirali B. Bukhari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amirali B. Bukhari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amirali B. Bukhari. The network helps show where Amirali B. Bukhari may publish in the future.

Co-authorship network of co-authors of Amirali B. Bukhari

This figure shows the co-authorship network connecting the top 25 collaborators of Amirali B. Bukhari. A scholar is included among the top collaborators of Amirali B. Bukhari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amirali B. Bukhari. Amirali B. Bukhari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Myt1 overexpression mediates resistance to cell cycle and DNA damage checkpoint kinase inhibitors 2023 ·Frontiers in Cell and Developmental Biology ·(unknown),Cody W. Lewis,Amirali B. Bukhari,J. A. Hadfield,(unknown),(unknown),(unknown),Wen‐Hsin Hsu,Armin M. Gamper,Gordon K. Chan	5
2	Radiation combined with oncolytic vaccinia virus provides pronounced antitumor efficacy and induces immune protection in an aggressive glioblastoma model 2023 ·Cancer Letters ·(unknown),(unknown),Ryan S. Noyce,Amirali B. Bukhari,Xuefei Han,(unknown),(unknown),Armin M. Gamper,Roseline Godbout,David H. Evans,Mary Hitt	11
3	Targeting the DNA Damage Response for Cancer Therapy by Inhibiting the Kinase Wee1 2022 ·Frontiers in Oncology ·Amirali B. Bukhari,Gordon K. Chan,Armin M. Gamper	39
4	EpCAM-Mediated Cellular Plasticity Promotes Radiation Resistance and Metastasis in Breast Cancer 2021 ·Frontiers in Cell and Developmental Biology ·(unknown),Amirali B. Bukhari,Ram Kumar Singh,Aastha Kapoor,Amlan Barai,Ishan Deshpande,Tabassum Wadasadawala,Pritha Ray,Shamik Sen,Abhijit De	24
5	Docosahexaenoic Acid in the Inhibition of Tumor Cell Growth in Preclinical Models of Ovarian Cancer 2021 ·Nutrition and Cancer ·(unknown),(unknown),(unknown),Marnie Newell,Amirali B. Bukhari,Armin M. Gamper,(unknown),Jiahui Liu,Julia Schueler,Gabrielle M. Siegers,Catherine J. Field,Lynne‐Marie Postovit	9
6	Upregulation of Myt1 Promotes Acquired Resistance of Cancer Cells to Wee1 Inhibition 2019 ·Cancer Research ·Cody W. Lewis,Amirali B. Bukhari,(unknown),Wonshik Choi,(unknown),Ellen Homola,John R. Mackey,Shelagh D. Campbell,Armin M. Gamper,Gordon K. Chan	47
7	Inhibiting Wee1 and ATR kinases produces tumor-selective synthetic lethality and suppresses metastasis 2019 ·Journal of Clinical Investigation ·Amirali B. Bukhari,Cody W. Lewis,(unknown),(unknown),Gordon K. Chan,Armin M. Gamper	99
8	Enhanced EPR directed and Imaging guided Photothermal Therapy using Vitamin E Modified Toco-Photoxil 2018 ·Scientific Reports ·Deepak S. Chauhan,Amirali B. Bukhari,Gayathri Ravichandran,(unknown),(unknown),(unknown),(unknown),Aravind Kumar Rengan,Asifkhan Shanavas,Rohit Srivastava,Abhijit De	24
9	α-Actinin-4 confers radioresistance coupled invasiveness in breast cancer cells through AKT pathway 2017 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Sejal Desai,Amlan Barai,Amirali B. Bukhari,Abhijit De,Shamik Sen	23
10	Soft drug-resistant ovarian cancer cells migrate via two distinct mechanisms utilizing myosin II-based contractility 2017 ·Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Aastha Kapoor,Amlan Barai,Bhushan Thakur,Alakesh Das,(unknown),(unknown),Snehal Gaikwad,Amirali B. Bukhari,(unknown),Abhijit Majumder,Abhijit De,Pritha Ray,Shamik Sen	22
11	In Vivo Analysis of Biodegradable Liposome Gold Nanoparticles as Efficient Agents for Photothermal Therapy of Cancer 2015 ·Nano Letters ·Aravind Kumar Rengan,Amirali B. Bukhari,Arpan Pradhan,Renu Malhotra,Rinti Banerjee,Rohit Srivastava,Abhijit De	324
12	IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samplesbreakdown → 2014 ·PLoS ONE ·Frency Varghese,Amirali B. Bukhari,Renu Malhotra,Abhijit De	992
13	Dietary curcumin post-treatment enhances the disappearance of B(a)P-derived DNA adducts in mouse liver and lungs 2014 ·Toxicology Reports ·Gaurav Kumar,(unknown),Amirali B. Bukhari,Asha G. Ramchandani,Abhijit De,Girish B. Maru	12
14	Quantitative Immunohistochemical Analysis Reveals Association between Sodium Iodide Symporter and Estrogen Receptor Expression in Breast Cancer 2013 ·PLoS ONE ·Sushmita Chatterjee,Renu Malhotra,Frency Varghese,Amirali B. Bukhari,Asawari Patil,Ashwini Budrukkar,Vani Parmar,Sudeep Gupta,Abhijit De	55
15	Cellular responses to gravity: Extracellular, intracellular and in-between 1998 ·Advances in Space Research ·Paul Todd,David M. Klaus,Louis Stodieck,Jeffrey D. Smith,L. Andrew Staehelin,Melissa A. Kacena,Barbara Manfredi,Amirali B. Bukhari	9

About Amirali B. Bukhari

Amirali B. Bukhari is a scholar working on Biophysics, Cell Biology and Physiology, having authored 15 papers that have together received 1.7k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (3 papers), Cancer-related Molecular Pathways (3 papers) and Cellular Mechanics and Interactions (2 papers). The work is most often cited by research in Biomaterials (189 citations), Oncology (347 citations) and Cancer Research (186 citations). Amirali B. Bukhari has collaborated with scholars based in India, Canada and China. Frequent co-authors include Abhijit De, Renu Malhotra, Frency Varghese, Rohit Srivastava, Aravind Kumar Rengan, Arpan Pradhan, Rinti Banerjee, Armin M. Gamper, Gordon K. Chan and Cody W. Lewis. Their work appears in journals such as Journal of Clinical Investigation, Nano Letters and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact